Private investment firm Inverness Graham’s Governance, Risk and Compliance (GRC) solutions company, Syntrio, has acquired ClearView Strategic Partners (ClearView), a provider of ethics reporting & management systems and whistleblower technology solutions. The transaction marks the fifth add-on acquisition completed during Inverness Graham’s ownership, and will provide Syntrio with access to

Vensica Therapeutics (Vensica), a clinical stage biopharmaceutical company, has closed a USD19 million investment round. Vensica executed a strategic collaboration agreement with Merz Therapeutics in 2021 and the Merz Group is participating in Vensica’s financing with up to USD3 million, bringing the total round to up to USD19 million. The

Reliance Health, an emerging markets-focused digital healthcare provider, has secured USD40 million in a Series B funding round led by General Atlantic. Partech, Picus Capital, Tencent Exploration, AAIC (Asia Africa Investment and Consulting), P1 Ventures, Laerdal Million Lives Fund, M3, Inc, and Arvantis Social Foundation also participated. With this funding,